EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Quality of life over time after new onset refractory status epilepticus

Matthew D Gruen, Margaret T Gopaul, Anthony D Jimenez iD, Ayush Batra iD, Leah J Blank iD, Charlotte Damien iD, Gregory S Day, Krista Eschbach iD, Elizabeth E Gerard, Teneille E Gofton iD, Stephen T Hantus, Nathalie Jette iD und 18 weitere

Epilepsia · 2026-01 · 67 (1) · 328-340

DOI: 10.1111/epi.18635 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Epilepsia, online erschienen am 13.09.2025. Verfasst von Matthew D Gruen und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Comprehensive Epilepsy Center, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Status Epilepticus, Quality of Life, Drug Resistant Epilepsy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, the Daniel Raymond Wong Neurology Research Fund at Yale, NORSE/FIRES Research Fund at Yale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aims to better characterize the long‐term neurological quality of life (QOL) outcomes (using the Neuro‐QOL scale) in survivors of new onset refractory status epilepticus (NORSE), including its subtype febrile infection‐related epilepsy syndrome (FIRES), and provide guidance for psychological and social support strategies.

Methods

Utilizing data from a multicenter prospective study of NORSE/FIRES led by Yale University, we enrolled patients who completed the validated, patient‐reported Neuro‐QOL scale at least once at 3–6 months ( n = 37), 12 months ( n = 29), 24 months ( n = 23), or ≥36 months ( n = 9) following discharge. The Neuro‐QOL scale assesses physical, mental, and social health in patients with neurological disorders. QOL impairment (QOL‐I) scores were calculated, with higher scores indicating greater impairment. T ‐scores enabled comparisons with reference populations.

Results

In adults, median QOL‐I improved from 44.1% at 3–6 months to 37.6% at 36+ months. Paired analysis showed significant improvement in QOL‐I between 3–6 and 24 months ( p = .016), with specific improvements in communication, satisfaction with social roles, fatigue, and mobility. Greater improvement was also observed for participation in social roles (5.5‐point T ‐score gain) compared to the reference population, suggesting meaningful change. A gradual improvement in overall QOL‐I scores was also observed in pediatric participants, despite a modest sample size ( n = 5 with data at 3–6 and 12 months). Measures of fatigue and anxiety persisted in adults, and cognitive difficulties persisted in both adults and children. In adults, longer status epilepticus duration and intensive care unit stay were associated with poorer QOL. Additionally, a higher number of antiseizure medications was associated with more depression, cognitive impairments, and perceived stigma. Significance These findings highlight the potential for recovery following an acute episode of NORSE, although many patients continue to face challenges requiring ongoing support, and the clinical meaning of the reported QOL improvement remains unclear. Furthermore, the findings underscore the importance of strategic multidisciplinary support systems in the years following discharge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Status EpilepticusQuality of LifeDrug Resistant EpilepsyHumansMaleFemaleAdultMiddle AgedYoung AdultProspective StudiesAdolescentAgedChildTime Factors

Stichwörter der Autor:innen

new onset refractory status epilepticusoutcomequality of life

Autor:innen und Institutionen

  • Department of Neurology, Comprehensive Epilepsy Center, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Neurology, Hôpital Universitaire de Bruxelles-Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
  • Department of Neurology, Washington University School of Medicine, Saint Louis, Missouri, USA.
  • Department of Neurology, Mayo Clinic in Florida, Jacksonville, Florida, USA.

ORCID-Profile: Anthony D Jimenez, Ayush Batra, Leah J Blank, Charlotte Damien, Krista Eschbach, Teneille E Gofton, Nathalie Jette, Vineet Punia, Olga Taraschenko, Ji Yeoun Yoo, Lawrence J Hirsch, Aurélie Hanin

Förderung

  • NIA NIH HHS
  • the Daniel Raymond Wong Neurology Research Fund at Yale
  • NORSE/FIRES Research Fund at Yale

Zitieren

APA

Gruen, M. D., Gopaul, M. T., Jimenez, A. D., Batra, A., Blank, L. J., Damien, C., Day, G. S., Eschbach, K., Gerard, E. E., Gofton, T. E., Hantus, S. T., Jette, N., Jongeling, A., Kang, P., Kazazian, K., Kellogg, M., Kim, M., Madani, B., Morales, M., …, & Hanin, A. (2026). Quality of life over time after new onset refractory status epilepticus. Epilepsia, 67(1), 328-340. https://doi.org/10.1111/epi.18635

Vancouver

Gruen MD, Gopaul MT, Jimenez AD, Batra A, Blank LJ, Damien C, et al. Quality of life over time after new onset refractory status epilepticus. Epilepsia. 2026;67(1):328-340. doi:10.1111/epi.18635

BibTeX
@article{Gruen2026,
  author = {Gruen, Matthew D and Gopaul, Margaret T and Jimenez, Anthony D and Batra, Ayush and Blank, Leah J and Damien, Charlotte and Day, Gregory S and Eschbach, Krista and Gerard, Elizabeth E and Gofton, Teneille E and Hantus, Stephen T and Jette, Nathalie and Jongeling, Amy and Kang, Peter and Kazazian, Karnig and Kellogg, Marissa and Kim, Minjee and Madani, Bahar and Morales, Mikaela and Punia, Vineet and Steriade, Claude and Struck, Aaron and Taraschenko, Olga and Torcida, Nathan and Wainwright, Mark S and Yoo, Ji Yeoun and Gaspard, Nicolas and Wong, Nora and Hirsch, Lawrence J and Hanin, Aurélie},
  title = {Quality of life over time after new onset refractory status epilepticus},
  journal = {Epilepsia},
  year = {2026},
  volume = {67},
  number = {1},
  pages = {328--340},
  doi = {10.1111/epi.18635}
}
Kostenlos starten →